What are the benefits of lion's mane tablets?

The mushroom's sheet, identical in every format: two small studies, the bench, and no claim, so that a tablet promising more than a capsule is promising the same file in a harder shape

What are the benefits of lion's mane tablets is a question that bundles two sheets together, and the honest page splits them, because the first sheet does not change when the mushroom is pressed into a tablet and the second has nothing to do with the mushroom at all. The mushroom's sheet first, since it is the one the buyer actually cares about and the one the tablet's marketing borrows. The human evidence for lion's mane is the same whether the material arrives as a tablet, a capsule, a loose powder or a coffee, because digestion does not know the shape: a sixteen-week double-blind trial from Japan in which thirty adults aged fifty to eighty with mild cognitive impairment took 3g a day of dried fruiting body powder, as it happens in tablet form, and whose cognitive scale scores rose above placebo over the sixteen weeks and fell back towards it during a four-week washout; a young-adult pilot in which a single 1.8g dose produced a faster Stroop test at sixty minutes and four weeks of daily dosing produced no clear chronic effect on cognition, stress or mood; a four-week study of thirty menopausal women eating cookies that measured mood questionnaires; and a body of bench work on the hericenones and erinacines, which stimulate nerve growth factor synthesis in cell culture and animal models and have never been shown to do anything measurable in a human nerve. There is no authorised UK health claim for lion's mane, cognitive or otherwise, so no tablet, capsule or sachet may print a sentence about focus, memory or the brain, and this site describes the studies as studies: small, real, unreplicated at scale, and modest. That is the whole of the mushroom's sheet, and it is identical on a tablet, which means a tablet product promising more than a capsule product is promising the same two studies and the same bench work in a harder shape, and a buyer who reads a tablet's benefits list should recognise it as the capsule's list with the word tablet substituted. The one place the format touches the mushroom's sheet is a footnote in the tablet's favour: the trial that produced the sixteen-week result used tablets, 250mg of 96 percent dry powder, four tablets three times a day, so the tablet is the format the strongest study actually tested, which says something about tablets' capacity and nothing about their superiority, since the powder inside was the point.

The tablet's own sheet: what compression buys, what excipients and disintegration cost, the market tendency to plain powder, and how to read a tablet like any other format

The tablet's own sheet is real but modest, and it is a sheet of format facts. In the tablet's favour, first, compression: a tablet is a powder pressed under force into a solid, and it can hold more material per unit than a capsule of comparable size, since a capsule is limited by the volume of its shell and a tablet by how hard the press can squeeze, which is exactly why the sixteen-week trial could deliver 3g a day in twelve 250mg tablets and why a tablet can carry a gram where a capsule carries half of one. Second, no shell: a tablet has no capsule around it, so the gelatine question that sends vegans reading the small print on capsules does not arise, though a coating, if there is one, is read for the same reason. Third, cost: tablets are often the cheapest format per gram of material, since compression is a cheap step and a shell is a bought component. Against the tablet, the costs are also format facts. Excipients: a tablet needs binders to hold it together, disintegrants to make it fall apart in the stomach, lubricants to release it from the press and sometimes a coating to make it swallowable, so a tablet's ingredients list is longer than a capsule's and a buyer who wants nothing but mushroom and shell reads it. Disintegration: a capsule shell dissolves in minutes and releases a loose powder, while a tablet must break apart, which a well-made tablet does in the same time and a poorly made one does slowly or incompletely, a difference the formulation controls and the buyer cannot see. A harder swallow: a gram-sized tablet is a large object, and the trial's twelve a day is a reason tablets are not the consumer format of choice. And the market tendency: lion's mane tablets on the UK shelf are more often plain milled fruiting body or mycelium powder, labelled in milligrams with no ratio, than stated extracts, which has nothing to do with compression and everything to do with which brands choose tablets, but means a tablet buyer reads the tissue, the extract ratio, the beta-glucan figure and the testing exactly as a capsule buyer does, and treats a tablet with no ratio as a powder tablet. So the benefits of lion's mane tablets, honestly stated, are the mushroom's thin file in a format that holds more, costs less, has no shell and asks the buyer to swallow more excipient and more tablet; a lifter who prefers tablets buys a stated extract tablet and gets the same two studies, and a lifter who prefers one small capsule buys the capsule version of the same sheet: a stated 5:1 fruiting body extract labelled 1500mg mushroom equivalent, 120 capsules for £15.49, 120 days at 13p, vegan HPMC shell, UK made under GMP and BRC, independently lab tested, with the extract and the equivalent both printed.

What to check on the label